Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hearing Loss × Hyaluronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Voice Disorders 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pleural Diseases 1 Papilloma 1 Ototoxicity 1 Non-Muscle Invasive Bladder Neoplasms 1 Mesothelioma 1 Laryngeal Neoplasms 1 Hearing Loss 1 Head and Neck Neoplasms 1 Goiter 1

Interventions

sodium thiosulfate 1 ebselen 1 Tomography, X-Ray Computed 1 Sodium Chloride 1 Magnetic Resonance Imaging 1 Hyaluronic Acid 1 Hearing Tests 1 Genetic Association Studies 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Decibel Therapeutics

Phase 1 Completed

Ototoxicity, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡